DynamX Medical
PRIVATE
STATUS
2ndary - Private
LATEST DEAL TYPE
8
INVESTORS
Description
Developer of biopsy triaging system designed to identify healthy and benign tissue specimens with high accuracy. The company's system helps to do healthy biopsies which could be quickly identified, before undergoing any processing and eliminated from the histopathology pathway, enabling physicians to treat their patients in an enhanced way.
Website
Formerly Known As
BeamLine Diagnostics
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Devices and Supplies
Other Healthcare Technology Systems
Primary Office
- Rutherford Appleton Laboratories
- Building R103 Office R-103, Harwell Campus
- Didcot OX11 0QX
- England, United Kingdom
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore DynamX Medical’s full profile, request a free trial.
DynamX Medical Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Secondary Transaction - Private | 00.000 | Completed | Generating Revenue | |||
| 6. Accelerator/Incubator | 12-Jun-2018 | 00000 | 00.000 | Completed | Generating Revenue | |
| 5. Early Stage VC | 07-Jun-2017 | 00000 | 00.000 | 00.000 | Completed | Generating Revenue |
| 4. Early Stage VC | 05-Apr-2016 | 00000 | 00000 | 00000 | Completed | Generating Revenue |
| 3. Accelerator/Incubator | 01-Jan-2016 | Completed | Generating Revenue | |||
| 2. Grant | 23-Jun-2015 | $10K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 01-Mar-2015 | Completed | Generating Revenue |
DynamX Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| Ordinary | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 00.000 | |
| Ordinary | 21,946 | $0.001291 | $8.82 | $8.82 | 1x | $8.82 | 12.46% |
DynamX Medical Investors (8)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| MedTech Innovator | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Angel Academe | Accelerator/Incubator | Minority | 000 0000 | 000000 0 | ||
| Angels in Med City | Angel Group | Minority | 000 0000 | 000000 0 | ||
| London Co-Investment Fund | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Founder.org | Accelerator/Incubator | 000 0000 | 000000 0 |
DynamX Medical Executive Team (4)
1 Former Executive
You’re viewing 3 of 4 executives. Get the full list »DynamX Medical Board Members (7)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Ian Smith | Self | Chairman | 000 0000 | |
| Katherine Willetts Ph.D | DynamX Medical | Board Member, Co-Founder & Chief Operating Officer | 000 0000 | |
| Liberty Foreman Ph.D | DynamX Medical | Board Member, Co-Founder & Chief Executive Officer | 000 0000 | |
| Savvas Neophytou Ph.D | Deepbridge Capital | Board Member | 000 0000 | |
| Tim Mustill | DynamX Medical | Board Member | 000 0000 |
2 Former Board Members
You’re viewing 5 of 7 board members. Get the full list »